› 5mov

X-ray diffraction
2.2Å resolution

Crystal structure of Ck2alpha with ZT0633 bound

Released:
DOI: 10.2210/pdb5mov/pdb
PDB entry 5mov coloured by chain, front view.
PDB entry 5mov coloured by chain, side view.
PDB entry 5mov coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
De Fusco C, Brear P, Iegre J, Georgiou KH, Sore HF, Hyvönen M, Spring DR
Bioorg Med Chem 25 3471-3482 (2017)
PMID: 28495381

Function and Biology Details

Reaction catalysed: 
ATP + a protein = ADP + a phosphoprotein
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-159383 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Casein kinase II subunit alpha Chain: A
Molecule details ›
Chain: A
Length: 325 amino acids
Theoretical weight: 38.72 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli BL21(DE3)
UniProt:
  • Canonical: P68400 (Residues: 3-327; Coverage: 83%)
Gene names: CK2A1, CSNK2A1
Sequence domains: Protein kinase domain
Structure domains:

Ligands and Environments

1 bound ligand:
Ligand HC4 1 x HC4
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: BRUKER AXS MICROSTAR
Spacegroup: P21
Unit cell:
a: 58.149Å b: 45.356Å c: 63.154Å
α: 90° β: 111.67° γ: 90°
R-values:
R R work R free
0.209 0.206 0.269
Expression system: Escherichia coli BL21(DE3)

Quick links

Citations

4 review citations

In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery.
de Souza Neto et al. (2020)
3 more

2 mentions without citation

A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
De Fusco et al. (2017)
1 more